Association of Immune-Related Adverse Events and Efficacy Outcomes With Consolidation Pembrolizumab After Chemoradiation in Patients With Inoperable Stage III Non-Small-Cell Lung Cancer.
Shukla, Nikhil Atul⋅Althouse, Sandra⋅Meyer, Zachary⋅Hanna, Nasser and Durm, Greg
Clinical lung cancer, January 23, 2021. | Journal Article